NEW YORK and LONDON, September 16th, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced that Dr. Gur Roshwalb, Chief Executive Officer, will present at two upcoming investor conferences:
Ladenburg Thalmann 2016 Healthcare Conference in New York City on Tuesday, September 27, 2016 at 12:00 pm ET.
LEERINK Partners Roundtable Series: Rare Disease Day 2016 in New York City on Wednesday, September 28, 2016 at 10:35 am ET.
